findmyKOL
Clinical trialNCT00637923CompletedPhase 2Interventional

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients

SponsorRomark Laboratories L.C.Enrollment112Chronic Hepatitis C
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Palo Alto Va Healthcare System

    Palo Alto, California, United States

  • Yale University School of Medicine

    New Haven, Connecticut, United States

  • Bay Pines Va Healthcare System

    Bay Pines, Florida, United States

  • Florida Center for Gastroenterology

    Largo, Florida, United States

  • Atlanta Gastroenterology Associates

    Atlanta, Georgia, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • New York Presbyterian-Weill Medical College of Cornell University

    New York, New York, United States

  • Nashville Medical Research Institute

    Nashville, Tennessee, United States

  • Metropolitan Research

    Fairfax, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2008
Primary completion
30 Apr 2010
Completion
30 Apr 2010
Last update posted
10 Feb 2014
Registered enrollment
112
Registry id
NCT00637923

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.